From three digits to single digits, what is the logic of nucleic acid detection price adjustment?

"In the face of huge social demand, high-priced necessities will fall flat under the effect of tim.

How big is the social need?

On April 16 this year, Li Jinming, deputy director of the National Health and Medical Commission's Clinical Testing Center, confirmed to the public: "Since the outbreak of the new crown epidemic, China has completed about 15 billion nucleic acid test.

Behind the national mutual recognition of nucleic acid test results is "the top priority of reducing costs and increasing efficiency.

In order to maximize the convenience of citizens to carry out testing, the Beijing Municipal Medical Insurance Bureau stated that since May 3, nucleic acid testing in the city will be free for citizens, and the required expenses will be jointly borne by financial funds and medical insurance fund.

At that time, when there was an unprecedented huge demand, a group of test kit manufacturers and nucleic acid testing service providers (except medical and health institutions) special business volume, achieved explosive growt.

The focus of public opinion controversy has shifted from "who will pay" to "how much to pay", and also from "how much to earn" to "who earns.

Two years ago, the initial price of nucleic acid testing was 200 yuan per perso.

In April 2020, Hubei took the lead in launching the centralized procurement of new coronavirus detection kits: the lowest winning price was 178 yuan, and the highest was 299 yuan; on June 15, 2020, Beijing announced the results of the online transaction for the joint purchase of Beijing-Tianjin-Hebei new coronavirus-related detection reagents "Display: 11 nucleic acid detection reagent products were sold online, with a minimum price of 12 yua.

On September 7, 2021, the Beijing-Tianjin-Hebei-Lu alliance centralized procurement: 22 nucleic acid detection kits were included, and the lowest supply price was as low as 38 yua.

From keeping an eye on the selected price of nucleic acid testing kits, to the government-guided price of nucleic acid testing services, to the fact that people in areas where normalized nucleic acid testing is implemented have not paid attention to the relevant pricing because they receive nucleic acid testing for fre.

It is still of great practical significance to discuss the pricing logic and pricing level of nucleic acid testin.

Nucleic acid testing is incomplete competition, and there are also market access, medical insurance access, regional access, hospital access and other barrier.

Nucleic acid detection reagents (and services) that are "consistent" by different suppliers are grouped according to market shar.

Whoever has a larger market share will be more profitable to maintain the original pric.

Whoever has a small market share will be encouraged to make a competitive offer within a reasonable range that meets operating cost.

Some people have long believed that "in the field of nucleic acid testing, on the one hand, it is a regulated action by the state to regulate social costs; on the other hand, it pays high prices for low-cost test.

Once, the earning ability of nucleic acid testing was comparable to printing mone.
If the liter is weighed, what is the terminal price of one liter of nucleic acid detection reagents?

At present, the price of medical masks has been reduced to a few cents a piece, and the production cost and process of masks are also more complicated, perhaps more complicated than nucleic acid reagent.
Although multiple rounds of centralized collection have greatly reduced the price of nucleic acid testing, people did not understand the process and felt that the price of nucleic acid testing at that time was still relatively expensiv.

Perhaps the pricing of nucleic acid testing does not have to be unified, but it can be coordinate.
Different suppliers need to work together in the same battle against the epidemic, taking into account the comprehensive consideration of sales volume (service volume), cost level, competition situation, and user economic bearin.

This work needs to rely on the power of market operation, but it cannot be done in accordance with the market's complete flexibility or obvious market failur.
The ideal scenario is: there are some differences in different pricing, and they are distributed in a reasonable range; production capacity regulation and moderate competitio.

Nucleic acid testing may be collected or collected by other method.
From the perspective of public management, the most important thing is actually the linkage of formulating payment standards, dynamic adjustment, and access efficienc.

From the perspective of industrial development, in order to encourage research and development, it is precisely necessary to compete reasonably and reduce prices in an orderly manner, and reasonable profits can also ensure the needs of research and developmen.
Nucleic acid testing is not yet a "patent period" product or service, which requires dialectical and defining the relationship between R&D and production, as well as the relationship between production and OE.

Nucleic acid detection reagents can be collected in a centralized manner, and nucleic acid detection services are packaged service.
Can we avoid the link between volume and price and instead seek to retain the balance? The matter was originally simple, but it deduced many situation.
Therefore, the allocation of nucleic acid testing fees needs to be adjuste.
Whether it is the direct inspection of the production enterprise or the inspection team sent by the epidemic prevention department, the reasonable remuneration of the manpower sinking cost should be paid attention to in the cos.

Compared with the epidemic in 2003, today's society has mastered nucleic acid detection technology and general application capabilities, and nucleic acid detection technology has also caught up with the reality of large-scale, urgent and continuous need.
To a certain extent, the mandatory policy of normalized nucleic acid testing has awakened people's health awareness, and nucleic acid testing has also started the process of market-oriented competitio.

No matter how nucleic acid testing changes, as long as it is on the track of progress in fairness and efficiency, it is worth encouragin.